Department of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, People's Republic of China.
Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China.
J Cancer Res Clin Oncol. 2024 Aug 22;150(8):393. doi: 10.1007/s00432-024-05898-w.
BACKGROUND/OBJECTIVE: Omics technology has become a widely applied biological science that can be used to study the etiology, pathogenesis, and treatment of osteosarcoma(OS). Bibliometric analysis is still blank in this field.This study aimed to access the trends and hotspots of omics in OS research through the bibliometric analysis method. METHODS: Relevant articles and reviews from 1999 to 2023 were retrieved from the Web of Science Core Collection. The data were processed with CiteSpace, and some graphs were generated with Graphpad, VOSviewer, Scimago Graphica, Bibliometrix and R Studio. RESULTS: A total of 1581 papers were included. China (569, 36.0%) and the United States (523, 33.1%) took the dominant position in the number of published papers, and the links between countries most frequently occurred between North America and East Asia, and between Australia and Europe. Top institutions with the highest number of publications were almost located in the United States, with The University of Texas MD Anderson Cancer Center contributing the most (44, 2.78%). Among the researchers in this field, Cleton-Jansen AM was the author with the highest number of articles in the field (20, 1.27%). According to the keyword cluster analysis, most studies focused on the "comparative genomic hybridization" before 2012. The latest surge words "tumor microenvironment" and "immune infiltration" in the keyword heatmap indicate future research directions. CONCLUSION: Our study provided the current status of the omics research in OS on a global level and the hottest directions. The field of omics in OS was developing rapidly, and the main focuses of research were revealing the characteristics of tumor microenvironment of OS and how to activate the immune system to fight cancer cells. Research on the immune microenvironment and its relationship with genetic aberrations of OS will be a priority in the future.
背景/目的:组学技术已成为广泛应用的生物科学,可以用于研究骨肉瘤(OS)的病因、发病机制和治疗方法。该领域的文献计量分析仍属空白。本研究旨在通过文献计量分析方法评估组学在骨肉瘤研究中的趋势和热点。
方法:从 Web of Science 核心合集检索 1999 年至 2023 年的相关文章和综述。使用 CiteSpace 处理数据,并使用 Graphpad、VOSviewer、Scimago Graphica、Bibliometrix 和 R Studio 生成一些图表。
结果:共纳入 1581 篇论文。中国(569 篇,36.0%)和美国(523 篇,33.1%)在发表论文数量上占据主导地位,国家之间的联系最频繁发生在北美和东亚之间,以及澳大利亚和欧洲之间。发表论文数量最多的顶级机构几乎都位于美国,其中德克萨斯大学 MD 安德森癌症中心的贡献最大(44 篇,2.78%)。在该领域的研究人员中,Cleton-Jansen AM 是该领域发表文章最多的作者(20 篇,1.27%)。根据关键词聚类分析,大多数研究集中在 2012 年前的“比较基因组杂交”。关键词热图中的最新热门词“肿瘤微环境”和“免疫浸润”表明了未来的研究方向。
结论:本研究提供了全球范围内骨肉瘤组学研究的现状和热点。骨肉瘤组学领域发展迅速,研究重点主要在于揭示骨肉瘤肿瘤微环境的特征,以及如何激活免疫系统对抗癌细胞。未来,将优先研究骨肉瘤的免疫微环境及其与遗传异常的关系。
J Cancer Res Clin Oncol. 2024-8-22
Front Endocrinol (Lausanne). 2023
Endocr Metab Immune Disord Drug Targets. 2024
Front Immunol. 2023
J Cancer Res Clin Oncol. 2024-6-24
Front Cell Infect Microbiol. 2022
World J Gastrointest Oncol. 2025-5-15
Medicine (Baltimore). 2024-3-29
Nanomaterials (Basel). 2024-1-13
Biochim Biophys Acta Rev Cancer. 2024-1
Curr Mol Pharmacol. 2024